Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm Publication Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…Jieun Choe2020 年 7 月 26 日
The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development Blog The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development 3 key tips to set your pediatric program up for success with the RACE for…Lynne Georgopoulos, RN, MSHS, RAC2020 年 7 月 14 日
Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology Publication Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…Jieun Choe2020 年 7 月 14 日
Local Therapies for the Global COVID-19 Pandemic Blog Local Therapies for the Global COVID-19 Pandemic Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…Henri Merdjan2020 年 5 月 29 日
Applying decision analysis to drug development for COVID-19 & future pandemics Blog Applying decision analysis to drug development for COVID-19 & future pandemics This blog discusses how decision analysis approaches can help drug developers to better decisions under…Rajesh Krishna and Bill Poland2020 年 4 月 30 日
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? 网络研讨会点播 罕见病药物困境:价值大、价格高、准入受限? This webinar will explain how pricing has evolved for the rare disease drug market and…webdev2020 年 2 月 19 日
Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110 Publication Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110 webdev2020 年 1 月 17 日
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Publication Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosingwebdev2020 年 1 月 17 日
Simcyp: 20 Years of Innovation Brochure Simcyp:20 年的创新 The consortium members have partnered with Simcyp and Certara during the past 20 years to…webdev2019 年 10 月 4 日
Innovative Solutions for Fast-Tracking Drugs for Rare Diseases On-Demand Webinar 快速跟踪罕见病药物的创新解决方案 This webinar discussed which pharmaceutical payer strategies work and which don't in our rapidly changing…webdev2019 年 8 月 10 日